Purification and characterization of galactocerebrosidase from human lymphocytes. 1994

N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
Department of Pediatrics, Faculty of Medicine, Osaka University.

Galactocerebrosidase was purified about 22,600-fold using several hydrophobic column and gel filtration steps with a 4.8% recovery, from human lymphocytes. Its specific activity was 1.54 x 10(5) nmol/h/mg with tritium-labeled galactocerebroside as the substrate in the taurocholate system. The optimal pH for galactocerebroside was 4.2 in the taurocholate system and 4.6 in the cholate system. The Km values for galactocerebroside were 5 microM in the taurocholate system and 25 microM in the cholate system. The molecular weight of the purified enzyme was estimated to be 90 kDa by sodium dodecylsulfate polyacrylamide gel electrophoresis and gel filtration. However, 70, 50, 40, and 30 kDa bands were also recognized on SDS-PAGE. The N-terminal amino acid sequences of the 70 kDa molecule and the three 50 kDa molecules were the same as that of the 90 kDa molecule. The N-terminal amino acid sequences of the 40 and 30 kDa molecules were unique. A monoclonal antibody raised against the purified enzyme effectively immunoprecipitated galactocerebrosidase activity, and an affinity column prepared with this monoclonal antibody bound the 90 and 50 kDa proteins. These results suggest that this enzyme is probably processed from the 90 kDa protein.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005698 Galactosylceramidase An enzyme that hydrolyzes galactose from ceramide monohexosides. Deficiency of this enzyme may cause globoid cell leukodystrophy (LEUKODYSTROPHY, GLOBOID CELL). EC 3.2.1.46. Galactocerebrosidase,Galactosylceramide Galactosidase,Galactosylceramide beta-Galactosidase,Galactosylcerebroside beta-Galactosidase,Galactosidase, Galactosylceramide,beta-Galactosidase, Galactosylceramide,beta-Galactosidase, Galactosylcerebroside
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
September 1993, Biochimica et biophysica acta,
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
April 1985, The Journal of biological chemistry,
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
February 2009, Experimental dermatology,
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
September 1989, Biochemical and biophysical research communications,
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
July 1982, Journal of immunology (Baltimore, Md. : 1950),
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
March 1990, Journal of immunology (Baltimore, Md. : 1950),
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
October 1983, Cancer research,
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
January 2000, Advances in experimental medicine and biology,
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
January 1983, Transactions of the Association of American Physicians,
N Sakai, and K Inui, and M Midorikawa, and Y Okuno, and S Ueda, and A Iwamatsu, and S Okada
May 1983, The Journal of experimental medicine,
Copied contents to your clipboard!